These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24408089)

  • 41. Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents.
    Sato S; Kamata W; Okada S; Tamai Y
    Int J Hematol; 2021 Feb; 113(2):207-213. PubMed ID: 32949373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgM multiple myeloma: pathologic evaluation of a rare entity.
    King RL; Howard MT; Hodnefield JM; Morice WG
    Am J Clin Pathol; 2013 Oct; 140(4):519-24. PubMed ID: 24045549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous disease.
    Quinn J; Percy L; Glassford J; Somana K; Rodriguez-Justo M; Yong K
    Br J Haematol; 2010 Apr; 149(1):156-9. PubMed ID: 19995388
    [No Abstract]   [Full Text] [Related]  

  • 44. A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
    Scapinello G; Riva M; Branca A; Pizzi M; Bonaldi L; Martines A; Manni S; Visentin A; Trentin L; Semenzato G; Gurrieri C; Piazza F
    Ann Hematol; 2020 Nov; 99(11):2715-2717. PubMed ID: 32671454
    [No Abstract]   [Full Text] [Related]  

  • 45. CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity.
    Bataille R; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
    Haematologica; 2005 May; 90(5):706-7. PubMed ID: 15921396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
    Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
    Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mantle cell lymphoma mainly involving thoracic lesions: two case reports.
    Kosaka M; Koizumi T; Fukushima T; Wada Y; Agatsuma T; Yokoyama T; Kanda S; Kubo K; Shimojo H; Horie S; Asano N
    Intern Med; 2011; 50(14):1477-81. PubMed ID: 21757833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.
    Narita T; Inagaki A; Kobayashi T; Kuroda Y; Fukushima T; Nezu M; Fuchida S; Sakai H; Sekiguchi N; Sugiura I; Maeda Y; Takamatsu H; Tsukamoto N; Maruyama D; Kubota Y; Kojima M; Sunami K; Ono T; Ri M; Tobinai K; Iida S
    Blood Cancer J; 2015 Feb; 5(2):e285. PubMed ID: 25723856
    [No Abstract]   [Full Text] [Related]  

  • 49. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
    Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
    Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).
    Otsuki T; Wada H; Nakazawa N; Taniwaki M; Kouguchi K; Ohkura M; Uehira K; Isoda K; Yata K; Sakaguchi H; Yawata Y; Ueki A; Yamada O
    Leuk Lymphoma; 2001 Aug; 42(4):761-74. PubMed ID: 11697507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma.
    Meeus P; Stul MS; Mecucci C; Cassiman JJ; Van den Berghe H
    Cancer Genet Cytogenet; 1995 Aug; 83(1):25-7. PubMed ID: 7656199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.
    Shin HJ; Kim K; Lee JJ; Song MK; Lee EY; Park SH; Kim SH; Jang MA; Kim SJ; Chung JS
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):227-35. PubMed ID: 25812994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New variant t(9;11;14)(p22;q23;q24) suggests a translocation of 9p to 11q as the critical genetic event.
    Miura I; Yamaguchi A; Takatsu H; Miura AB
    Cancer Genet Cytogenet; 1993 Dec; 71(2):176-7. PubMed ID: 8281524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VH gene repertoire of mantle cell lymphomas.
    Varade W; Marin E; Milano M; Insel R; Swerdlow S; Williams M
    Ann N Y Acad Sci; 1995 Sep; 764():504-6. PubMed ID: 7486576
    [No Abstract]   [Full Text] [Related]  

  • 55. Translocation (11;14)(q13;q32) and partial trisomy 1q in a case of multiple myeloma.
    Kwong YL; Lie AK; Chan LC
    Am J Hematol; 1993 Nov; 44(3):212-3. PubMed ID: 8213777
    [No Abstract]   [Full Text] [Related]  

  • 56. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).
    Akiyama N; Tsuruta H; Sasaki H; Sakamoto H; Hamaguchi M; Ohmura Y; Seto M; Ueda R; Hirai H; Yazaki Y
    Cancer Res; 1994 Jan; 54(2):377-9. PubMed ID: 8275473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
    Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
    Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
    Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
    Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).
    Cleynen A; Samur M; Perrot A; Buisson L; Maheo S; Fulciniti M; Attal M; Munshi N; Avet-Loiseau H; Corre J
    Blood; 2018 Dec; 132(26):2778-2780. PubMed ID: 30429160
    [No Abstract]   [Full Text] [Related]  

  • 60. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
    Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
    Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.